The Nanowear Wearable Covid-19 Observational and Analysis Trend

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-15

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects

NCT04667442

Covid19

COMPLETED

Wearable Diagnostic for Detection of COVID-19 Infection

NCT04742569

COVID-19

COMPLETED

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

NCT04750629

SARS-CoV-2 Covid19

COMPLETED

Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)

NCT05403346

SARS-CoV-2 Covid19

TERMINATED

A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19

NCT04742712

SARS-CoV Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational Study - no intervention

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has provided informed consent
* Male or female over the age of 18 years
* The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion Criteria

* Subject is unwilling or unable to wear the vest during hospitalization.
* Subjects who are pregnant.
* Subject is intubated or admitted to ICU
* Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No